What is Aquestive Therapeutics, Inc. (AQST)?
Aquestive Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of proprietary drug delivery technologies and pharmaceutical products. The company focuses on creating novel formulations that improve the administration and efficacy of medications, often addressing challenges related to patient compliance and drug absorption. Aquestive Therapeutics employs innovative platforms to develop treatments for various medical conditions, including those requiring controlled or targeted drug delivery. Its product pipeline includes both internally developed drugs and licensed products, spanning multiple therapeutic areas. The company operates within the pharmaceutical and biotechnology sectors, emphasizing research and development, regulatory affairs, and commercialization strategies. Aquestive Therapeutics collaborates with healthcare providers and regulatory agencies to bring its products to market, aiming to enhance patient outcomes through improved drug delivery solutions.
Aquestive Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by ongoing trading, with Aquestive Therapeutics, Inc. priced at $4.0408. It has fluctuated between $3.9392 and $4.0692, marking a 0% change today.
FAQ: Aquestive Therapeutics, Inc. (AQST)
What is the current price of AQST stock?
Aquestive Therapeutics, Inc.'s last price is $4.0408.
Does AQST pay dividends?
Aquestive Therapeutics, Inc. pays dividends via cash distributions (if applicable).
Does AQST have a formal corporate presence or regional headquarters in the UAE?
Aquestive Therapeutics, Inc. does not maintain an official UAE office or subsidiary and operates via distributors.
What is AQST best known for?
The company is most famous for its pharmaceutical drug delivery technologies.
What assets are typically shown together with AQST?
Commonly shown alongside AQST: Novo Nisk Adr Repsg 1, ConvaTec Group, Arcus Biosciences, Inc.
Latest shares articles



